Who We Are

Lucence Diagnostics is a genomic medicine company focused on personalizing cancer care. We invent novel liquid biopsy tests for cancer detection and treatment. We target common cancers in Asia, such as cancers of the lung, breast, colon, liver and nasopharyngeal. We deliver our clinical services worldwide through an ISO 15189:2012 accredited laboratory.

Vision

A world without avoidable cancer deaths.

Mission

To achieve early cancer detection, better treatment and less suffering through deep genome intelligence.

Our Story

We see the fight against cancer as a mission. If we can deliver early detection for all cancers to achieve cure, that is something worth our time, our energy, everything.

Dr Min-Han Tan Founding CEO and Medical Director

The story of Lucence Diagnostics began in 1999, when our founder Dr Min-Han Tan (Han) was a medical resident at the university cancer center in Singapore. There he witnessed great suffering, but also saw the ability of modern medicine to alleviate unnecessary pain and distress. This formative experience motivated him to focus his life and career on understanding how to fight and defeat cancer through a deep understanding of the human genome. Han believes that oncology exists where bedside medicine, high technology, deep research and profound spirituality intersect.

Han first completed his medical oncology specialist training. He then went on to pursue his PhD in cancer genetics at the Karolinska Institute, Sweden and National University of Singapore. To seek deeper understanding on genomic medicine, Han joined the Cleveland Clinic in the United States as a research scholar, where he was awarded both the Lee Foundation and Ambrose Monell Cancer Genomic Medicine Fellowships. At the Cleveland Clinic, he and Professor Charis Eng published landmark data models on cancer risk in hereditary breast and thyroid cancers. This work continues to guide the international cancer community in patient care today.

In 2011, Han joined the Agency for Science, Technology and Research (A*STAR) to lead the Laboratory of Systems Medicine and focus on building better genomic technology for cancer patients. Over the next 5 years, Han and his team made key discoveries on the nature of circulating tumor DNA and circulating tumor cells by applying innovative laboratory and machine-learning technologies. His discovery of the circulating tumor-endothelial cluster transformed the liquid biopsy field and overturned decades of scientific dogma. This research led to improved non-invasive screening and profiling of cancer using blood testing.

Han founded Lucence in 2016 to deliver his genomic technology from the laboratory to the world where it was most needed. Lucence’s vision is a world without avoidable cancer deaths through early cancer detection and better treatment selection. The company’s AmpliMARK™ sequencing technology is used in its flagship liquid biopsy test LiquidHALLMARK® to detect cancer-causing mutations and viruses. Its AI platform SunTzu.AI™ centralizes genomic intelligence and maps cancer-fighting strategies for each patient.  

In 2017, Lucence raised US$9.2 million in seed funding, one of the largest seed investments raised by a biomedical start-up in Asia Pacific. Today, Lucence’s liquid biopsy tests are available across Asia to help doctors reduce the pain and sufferings of cancer patients.

Achieving a world without avoidable cancer deaths through genomic intelligence is at the core of everything Lucence does.

Read More

Milestones

March
2016

Company founded

August
2017

Raised US$9.2 million seed funding

September
2017

Received
ISO 15189:2012 accreditation

March
2018

Company expands to Hong Kong

August
2018

Company expands to San Francisco

April
2019

Company expands to Suzhou

Our Investors

We are a venture-backed company with the mission to fight cancer through earlier diagnosis and treatment. We are supported by a group of like-minded investors that understands how great technology is nurtured and developed, the positive impact it can have on lives, and the real difference it can make to humanity.

Our Partners

We partner with healthcare providers and medical laboratories to deliver our cancer diagnostic services to physicians. We also collaborate with hospitals, research institutes and universities to conduct studies that advance the field of genomic medicine.

Our Team

Min-Han Tan CEO and Medical Director
Yukti Choudhury Chief Technology Officer
Pan Zhao Chief Commercial Officer
Kevin Goh Chief Financial Officer
Wai Min Phyo Director,
Assays Development
Jamen Loh Director,
Business Development
Jack Challis Director,
Healthcare Analytics
Hao Chen Director,
Informatics
Jess Vo Director,
Operations
Hilary Kan Regional Director and Product Management Head
Aster Ding Market Lead (China)
Yvonne Sim Manager,
People & Organisational Development
Benson Lim General Counsel
Genevieve Low Assistant Corporate Counsel
Hilda Tan Manager,
Business Development
Jack Tang Senior Sales Manager,
Hong Kong
Kingman Chan Sales Manager,
Hong Kong
Yuzhen Tay Sales and Marketing Executive
Caitlin Chan Sales and Marketing Executive,
Hong Kong
Pow Jia Qi Sales Executive
Lay Kheng Tan Clinic Manager
Daniel Tan Kian Hin Clinical Scientist
Michelle Pek Research Scientist
Ngeow Kao Chin Research Scientist
Chae Yin Cher Research Scientist
Kim Tien Ng Scientific Officer
Siti Farah Bte Fadhlullah Senior Research Officer
Albert Ho Yi Liang Senior Full Stack Engineer
Thet Naing Aye Software Engineer
Chaitanya Gupta Data Scientist
Yong Herng Low Laboratory Manager
Melvin Wong Deputy Laboratory Manager
Michelle Tan Bee Kim Senior Medical Technologist
Ru Jin Tay Senior Medical Technologist
Marielle Luanzon Medical Technologist
Mai Quach Medical Technologist
Nicole Lim Medical Technologist
Ee Wern Kwong Junior Medical Technologist
Ong Geok Fong Junior Medical Technologist
Jennifer Ramlan Accounts Executive
Careers

Join Our Team

Lucence is a fast-growing genomic medicine company with offices in Singapore, San Francisco, Hong Kong and Suzhou.

We have assembled a dynamic team of physicians, scientists, geneticists, bioinformaticians and data analysts who are passionate about the work we do here to improve cancer care. We come from different backgrounds and nationalities but are focused on a single mission – to fight cancer and save lives.

Join our team to transform the way we fight cancer.
Click here to view our open positions.

Contact

Get In Touch

Customer Care Team +65 65925102 [email protected]

You can also contact us using the form below

Location

Our Offices

Singapore

Service Laboratory
211 Henderson Road, #04-02
Henderson Industrial Park
Singapore 159552

Tel: +65 6909 0390
Fax: +65 6725 0590

Genetics Clinic6 Napier Road, #04-03
Gleneagles Medical Centre
Singapore 258499

Tel: +65 6592 5102

Hong Kong

Rooms 05-15, 13A/F, South Tower
World Finance Centre
Harbour City, 17 Canton Road
Tsim Sha Tsui, Kowloon
Hong Kong

Tel: +852 5801 2340
Fax: +852 3012 9866

San Francisco

162 South Park Street
San Francisco
CA 94107
USA

Suzhou

2F, B6 Building
218 Xinghu Street
Suzhou Industrial Park
China 215123

Need Help?